Cargando…

Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4(+) T cells from HIV-1 infection

BACKGROUND: The main approach to treat HIV-1 infection is combination antiretroviral therapy (cART). Although cART is effective in reducing HIV-1 viral load and controlling disease progression, it has many side effects, and is expensive for HIV-1 infected patients who must remain on lifetime treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhepeng, Chen, Shuliang, Jin, Xu, Wang, Qiankun, Yang, Kongxiang, Li, Chenlin, Xiao, Qiaoqiao, Hou, Panpan, Liu, Shuai, Wu, Shaoshuai, Hou, Wei, Xiong, Yong, Kong, Chunyan, Zhao, Xixian, Wu, Li, Li, Chunmei, Sun, Guihong, Guo, Deyin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591563/ https://www.ncbi.nlm.nih.gov/pubmed/28904745 http://dx.doi.org/10.1186/s13578-017-0174-2

Ejemplares similares

Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection
por: Wang, Qiankun, et al.
Publicado: (2017)

CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4(+) T cells and hematopoietic stem/progenitor cells promotes HIV-1 resistance and CD4(+) T cell enrichment in humanized mice
por: Xiao, Qiaoqiao, et al.
Publicado: (2019)

HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies
por: Liu, Shuai, et al.
Publicado: (2018)

Correction to: CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4(+) T cells and hematopoietic stem/progenitor cells promotes HIV-1 resistance and CD4(+) T cell enrichment in humanized mice
por: Xiao, Qiaoqiao, et al.
Publicado: (2019)

Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
por: Hou, Panpan, et al.
Publicado: (2015)

Genome editing of CCR5 by AsCpf1 renders CD4(+)T cells resistance to HIV-1 infection
por: Liu, Zhepeng, et al.
Publicado: (2020)

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection
por: Harms, Mirja, et al.
Publicado: (2023)

Macrocyclic polyamines inhibit HIV infection by interacting with the cellular HIV co-receptors CXCR4 and CCR5
por: Schols, Dominique, et al.
Publicado: (2009)

Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
por: Xiao, Qiaoqiao, et al.
Publicado: (2019)

CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy
por: Grande, Fedora, et al.
Publicado: (2019)

In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4
por: Higuita, Edwin A, et al.
Publicado: (2013)

Establishment of a novel CCR5 and CXCR4 expressing CD4(+ )cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists
por: Princen, Katrien, et al.
Publicado: (2004)

Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets
por: Kurbatska, Victoria, et al.
Publicado: (2010)

NK Cells Acquire CCR5 and CXCR4 by Trogocytosis in People Living with HIV-1
por: Vo, Dang-Nghiem, et al.
Publicado: (2022)

Therapeutic Perspectives of HIV-Associated Chemokine Receptor (CCR5 and CXCR4) Antagonists in Carcinomas
por: González-Arriagada, Wilfredo Alejandro, et al.
Publicado: (2022)

The HIV-1 Gp120/CXCR4 Axis Promotes CCR7 Ligand-Dependent CD4 T Cell Migration: CCR7 Homo- and CCR7/CXCR4 Hetero-Oligomer Formation as a Possible Mechanism for Up-Regulation of Functional CCR7
por: Hayasaka, Haruko, et al.
Publicado: (2015)

Signal Transduction Due to HIV-1 Envelope Interactions with Chemokine Receptors CXCR4 or CCR5
por: Davis, Craig B., et al.
Publicado: (1997)

CXCR4- and CCR5-Tropic HIV-1 Clones Are Both Tractable to Grow in Rhesus Macaques
por: Doi, Naoya, et al.
Publicado: (2018)

Host cell glycosylation selects for infection with CCR5- versus CXCR4-tropic HIV-1
por: Itell, Hannah L., et al.
Publicado: (2023)

Defining Differential Genetic Signatures in CXCR4- and the CCR5-Utilizing HIV-1 Co-Linear Sequences
por: Aiamkitsumrit, Benjamas, et al.
Publicado: (2014)

Expression of CCR5, CXCR4 and DC-SIGN in Cervix of HIV-1 Heterosexually Infected Mexican Women
por: Rivera-Morales, Lydia Guadalupe, et al.
Publicado: (2012)

Growth potentials of CCR5-tropic/CXCR4-tropic HIV-1mt clones in macaque cells
por: Doi, Naoya, et al.
Publicado: (2013)

Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV
por: Freen-van Heeren, Julian J.
Publicado: (2022)

Detection of HIV-1 Neutralizing Antibodies in a Human CD4(+)/CXCR4(+)/CCR5(+) T-Lymphoblastoid Cell Assay System
por: McLinden, Robert J., et al.
Publicado: (2013)

HIV-1 with Multiple CCR5/CXCR4 Chimeric Receptor Use Is Predictive of Immunological Failure in Infected Children
por: Cavarelli, Mariangela, et al.
Publicado: (2008)

Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes
por: Sloan, Richard D, et al.
Publicado: (2010)

CCR3, CCR4, CCR5, and CXCR3 expression in peripheral blood CD4+ lymphocytes in gastric cancer patients
por: Andalib, Alireza, et al.
Publicado: (2013)

Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and CXCR4 in squamous cell carcinoma of tongue and floor of the mouth
por: Domingueti, Catherine-Bueno, et al.
Publicado: (2019)

CCR5 and CXCR4 antagonist and agonist binding sites
por: Teintze, Martin, et al.
Publicado: (2006)

HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector
por: Anderson, Joseph, et al.
Publicado: (2005)

Introducing the issue on “Differential use of CCR5 versus CXCR4 by HIV-1. Pathogenic, Translational and Clinical Open Questions”
por: Poli, Guido, et al.
Publicado: (2011)

Detection of Inferred CCR5- and CXCR4-Using HIV-1 Variants and Evolutionary Intermediates Using Ultra-Deep Pyrosequencing
por: Bunnik, Evelien M., et al.
Publicado: (2011)

V3 Loop Sequence Space Analysis Suggests Different Evolutionary Patterns of CCR5- and CXCR4-Tropic HIV
por: Bozek, Katarzyna, et al.
Publicado: (2009)

Unique profile of predominant CCR5-tropic in CRF07_BC HIV-1 infections and discovery of an unusual CXCR4-tropic strain
por: Hu, Xiaoyan, et al.
Publicado: (2022)

Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection
por: Cashin, Kieran, et al.
Publicado: (2013)

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4
por: Di Marino, Daniele, et al.
Publicado: (2023)

Stable gene transfer of CCR5 and CXCR4 siRNAs by sleeping beauty transposon system to confer HIV-1 resistance
por: Tamhane, Mayur, et al.
Publicado: (2008)

Divergent Expression of CXCR5 and CCR5 on CD4(+) T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection
por: Zaunders, John, et al.
Publicado: (2017)

Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore‐based virtual screening approach
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Coexpression of CCR7 and CXCR4 During B Cell Development Controls CXCR4 Responsiveness and Bone Marrow Homing
por: Mcheik, Saria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n906mpns88g4eedtjtsmeuhcf2